Pay in 4 interest-free payments of $5.73 Learn more
Ships within 48 hours · Estimated delivery Aug 17 - Aug 22
NICE technology appraisal TA875 (2023) recommends semaglutide 2.4 mg (Wegovy) as an adjunct to a reduced-calorie diet and increased physical activity for adults with a BMI of 35 kg/m or above (or 3034.9 kg/m in certain circumstances) alongside at least one weight-related comorbidity, when initiated within specialist weight management services
Melanoblastoma of the nail-bed (Melanotic Whitlow)
A proper brain insulin action has been shown to improve mood and counteract cognitive dysfunction in dementia (215)
Regulator keeps close eye on GLP-1 weight loss drugs' possible link to suicidal thoughts How will Wegovy fit into obesity societys guidelines in Korea
US$ 23.27
US$ 28.23
US$ 28.78
US$ 27.99
US$ 22.05
